← Back to headlines
Biogen Acquires RayThera in Deal Valued Up to $1 Billion
Biogen has announced the acquisition of RayThera in a deal that could be worth up to $1 billion. This strategic move expands Biogen's portfolio and capabilities within the biotechnology sector.
18 Jun, 13:40 — 18 Jun, 13:40
Sources
Showing 1 of 1 sources
Related Stories
Climate Catastrophes in Europe Cost Billions, Burdening Citizens
25m ago
Former Google CEO Eric Schmidt Selling Superyacht for €149 Million
26m ago
Berkshire Hathaway's Significant Investment in Alphabet Stock
33m ago
Fabrinet Shares Decline Despite Earnings Beat Due to Margin and Cash Flow Concerns
49m ago